Independent · Reader-Supported · Editorially Reviewed
§ Brand Review · Primary Care

Wisp Review

Asynchronous sexual and reproductive healthcare for women across every life stage.

Last reviewed July 2026
4 studies cited
Fact-checked 18 July 2026Last updated 15 June 2026From $15 – $199/moEditor Score 4.5 / 5Trustpilot 4.1 · Great

Reader-supported, we may earn a commission through links on this site. Rankings are editorially independent. Disclosure · Methodology

Quick Verdict

Asynchronous sexual and reproductive healthcare for women across every life stage.

Who it's for: Wisp is the right pick when you want occasional, single-script care, a UTI prescription, an STI test kit, an emergency contraception order, without a recurring membership. Less suited as a primary GLP-1 provider.

Bottom line: An async, no-subscription specialist that nails the once-in-a-while women's-health use case. If you want sustained GLP-1 care, look at Eden, Gala Health, or PlushCare instead. The no-subscription model is the clearest differentiator — you pay per visit rather than a monthly fee, which makes Wisp cost-effective for occasional needs but expensive for sustained GLP-1 treatment.

Pros
  • Industry-leading $15 entry price
  • Asynchronous, no live visit required
  • Wide women's formulary including STI test kits and DoxyPEP
Cons
  • Not the right fit for chronic GLP-1 buyers
  • Compounded GLP-1 catalog is shallow versus specialists

Pros & Cons In Detail

Industry-leading $15 entry price
In practice this is one of the differentiators that pushes Wisp's editor score above the category median.
Asynchronous, no live visit required
In practice this is one of the differentiators that pushes Wisp's editor score above the category median.
Wide women's formulary including STI test kits and DoxyPEP
In practice this is one of the differentiators that pushes Wisp's editor score above the category median.
Not the right fit for chronic GLP-1 buyers
It's a real trade-off worth knowing about before you commit, even if it isn't a deal-breaker on its own.
Compounded GLP-1 catalog is shallow versus specialists
It's a real trade-off worth knowing about before you commit, even if it isn't a deal-breaker on its own.

Wisp Pricing

Telehealth ads often advertise a low headline price that's the clinic's program fee, not the medication. Here's how the two line items break down at Wisp.

Program / Membership FeeNo subscription required
Medication Cost (From)From $15 – $199/mo
What This Means For You

Wisp uses async, prescription-by-prescription pricing. there is no required monthly subscription. Each prescription is billed individually.

Who Wisp Is For

Wisp is the right pick when you want occasional, single-script care, a UTI prescription, an STI test kit, an emergency contraception order, without a recurring membership. Less suited as a primary GLP-1 provider.

How Wisp Markets Itself

Women, partners, and allies who want async sexual and reproductive healthcare without a recurring membership.

Signature Programs

  • ›UTI, yeast, and BV antibiotics
  • ›Birth control and emergency contraception
  • ›STI test kits and DoxyPEP

Medication Formulary

Full Formulary
sulfamethoxazole-trimethoprimnitrofurantoinmetronidazolefluconazolevalacycloviracyclovirnorethindroneemergency contraceptionbirth controlsti test kitssublingual semaglutidemetabolic supportdoxypeptopical spironolactonetretinoinmetformin

The Bottom Line

An async, no-subscription specialist that nails the once-in-a-while women's-health use case. If you want sustained GLP-1 care, look at Eden, Gala Health, or PlushCare instead. The no-subscription model is the clearest differentiator — you pay per visit rather than a monthly fee, which makes Wisp cost-effective for occasional needs but expensive for sustained GLP-1 treatment.

With an editor score of 4.5 / 5 across cost, experience, and trust, Wisp is one of the top-tier options in the primary care category we cover.

See how Wisp compares in our full primary care rankings, or read the Best Telehealth Providers for PCOS (2026) guide. Our methodology explains how we score each provider.

§ FAQ

Frequently Asked Questions

References
  1. Wilding et al., NEJM 2021 (STEP 1) · Semaglutide 2.4 mg produced 14.9% mean weight loss vs 2.4% placebo at 68 weeks in the STEP 1 trial.
  2. Garvey et al., NEJM 2022 (STEP 5) · Two-year STEP 5 data confirmed sustained 15.2% weight loss with semaglutide 2.4 mg.
  3. Kligman et al., JAAD 1986 (Tretinoin) · Landmark RCT establishing tretinoin efficacy for photoaging: significant improvement in fine lines, texture, and pigmentation.
  4. UKPDS Group, Lancet 1998 (Metformin) · UKPDS 34: metformin reduced diabetes-related endpoints by 32% and all-cause mortality by 36% vs conventional therapy.

RxNotebook is an editorial publication. Citations point to peer-reviewed journals, FDA labeling, and clinical society guidelines. We are not affiliated with the studies cited above. This page is for general information and is not medical advice.

§ Readers Also Compared

How Wisp Stacks Up

Alternatives To Wisp

§ Continue Reading